Literature DB >> 12110541

Free fatty acid-induced peripheral insulin resistance augments splanchnic glucose uptake in healthy humans.

Mandeep Bajaj1, Rachele Berria, Thongchai Pratipanawatr, Sangeeta Kashyap, Wilailak Pratipanawatr, Renata Belfort, Kenneth Cusi, Lawrence Mandarino, Ralph A DeFronzo.   

Abstract

To investigate the effect of elevated plasma free fatty acid (FFA) concentrations on splanchnic glucose uptake (SGU), we measured SGU in nine healthy subjects (age, 44 +/- 4 yr; body mass index, 27.4 +/- 1.2 kg/m(2); fasting plasma glucose, 5.2 +/- 0.1 mmol/l) during an Intralipid-heparin (LIP) infusion and during a saline (Sal) infusion. SGU was estimated by the oral glucose load (OGL)-insulin clamp method: subjects received a 7-h euglycemic insulin (100 mU x m(-2) x min(-1)) clamp, and a 75-g OGL was ingested 3 h after the insulin clamp was started. After glucose ingestion, the steady-state glucose infusion rate (GIR) during the insulin clamp was decreased to maintain euglycemia. SGU was calculated by subtracting the integrated decrease in GIR during the period after glucose ingestion from the ingested glucose load. [3-(3)H]glucose was infused during the initial 3 h of the insulin clamp to determine rates of endogenous glucose production (EGP) and glucose disappearance (R(d)). During the 3-h euglycemic insulin clamp before glucose ingestion, R(d) was decreased (8.8 +/- 0.5 vs. 7.6 +/- 0.5 mg x kg(-1) x min(-1), P < 0.01), and suppression of EGP was impaired (0.2 +/- 0.04 vs. 0.07 +/- 0.03 mg x kg(-1) x min(-1), P < 0.01). During the 4-h period after glucose ingestion, SGU was significantly increased during the LIP vs. Sal infusion study (30 +/- 2 vs. 20 +/- 2%, P < 0.005). In conclusion, an elevation in plasma FFA concentration impairs whole body glucose R(d) and insulin-mediated suppression of EGP in healthy subjects but augments SGU.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12110541     DOI: 10.1152/ajpendo.00329.2001

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  10 in total

1.  Non-esterified fatty acids impair insulin-mediated glucose uptake and disposition in the liver.

Authors:  P Iozzo; R Lautamaki; F Geisler; K A Virtanen; V Oikonen; M Haaparanta; H Yki-Jarvinen; E Ferrannini; J Knuuti; P Nuutila
Journal:  Diabetologia       Date:  2004-07-09       Impact factor: 10.122

2.  Puerarin improve insulin resistance of adipocyte through activating Cb1 binding protein path.

Authors:  Ying Zhao; You Zhou
Journal:  Chin J Integr Med       Date:  2012-03-30       Impact factor: 1.978

3.  Reassessing the evidence: prandial state dictates glycaemic responses to exercise in individuals with type 1 diabetes to a greater extent than intensity.

Authors:  Jane E Yardley
Journal:  Diabetologia       Date:  2022-08-18       Impact factor: 10.460

4.  Free fatty acid-induced hepatic insulin resistance is attenuated following lifestyle intervention in obese individuals with impaired glucose tolerance.

Authors:  Jacob M Haus; Thomas P J Solomon; Christine M Marchetti; John M Edmison; Frank González; John P Kirwan
Journal:  J Clin Endocrinol Metab       Date:  2009-11-11       Impact factor: 5.958

5.  Impaired regulation of the TNF-alpha converting enzyme/tissue inhibitor of metalloproteinase 3 proteolytic system in skeletal muscle of obese type 2 diabetic patients: a new mechanism of insulin resistance in humans.

Authors:  A Monroy; S Kamath; A O Chavez; V E Centonze; M Veerasamy; A Barrentine; J J Wewer; D K Coletta; C Jenkinson; R M Jhingan; D Smokler; S Reyna; N Musi; R Khokka; M Federici; D Tripathy; R A DeFronzo; F Folli
Journal:  Diabetologia       Date:  2009-07-25       Impact factor: 10.122

Review 6.  Fat-induced liver insulin resistance.

Authors:  Pankaj Shah; Ananda Basu; Robert Rizza
Journal:  Curr Diab Rep       Date:  2003-06       Impact factor: 4.810

7.  Portal infusion of escitalopram enhances hepatic glucose disposal in conscious dogs.

Authors:  Zhibo An; Mary C Moore; Jason J Winnick; Ben Farmer; Doss W Neal; Margaret Lautz; Marta Smith; Tiffany Rodewald; Alan D Cherrington
Journal:  Eur J Pharmacol       Date:  2009-04-01       Impact factor: 4.432

8.  Reduction of islet pyruvate carboxylase activity might be related to the development of type 2 diabetes mellitus in Agouti-K mice.

Authors:  J Han; Y Q Liu
Journal:  J Endocrinol       Date:  2009-11-12       Impact factor: 4.286

9.  Effect of plasma free fatty acid supply on the rate of ceramide synthesis in different muscle types in the rat.

Authors:  Piotr Zabielski; Agnieszka Urszula Błachnio-Zabielska; Beata Wójcik; Adrian Chabowski; Jan Górski
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

Review 10.  Type 2 diabetes in South Asians: a pathophysiologic focus on the Asian-Indian epidemic.

Authors:  Mandeep Bajaj; Mary Ann Banerji
Journal:  Curr Diab Rep       Date:  2004-06       Impact factor: 5.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.